Yr4 MSK - Lectures Flashcards
What is OA?
- Which joints are typically affected?
- OA is a group of overlapping genetic and mechanically driven disorders with similar morphologic features and clinical outcomes: end result is joint failure.
- Causation is unclear but genetic factors (heritability estimated at 40 – 70 %), and environmental factors such as occupation and joint injury are likely to be the major aetiologic contributors (e.g. farm workers have a 5 fold increased risk for hip OA).
Role of Ageing in OA?
Role of BMI in OA?
BMI (weight) and OA
* Obesity increases the risk of OA in females.
* Framingham data shows that a Wt. loss of 5 kg reduced the risk of Knee OA by a half and that weight loss (averaging 4kg) reduced knee pain.
* Decreased body mass improves mobility.
List 3 differences between OA and RA?
What is Erosive OA?
- What pattern on radiographs?
Erosive OA
* Probably a separate or unique disease (phenotype), however still a matter of conjecture
* Note the marked cartilage and central bone erosion
List 6 Signs & Symptoms of OA?
2 Classic clinical features?
Symptoms and Signs of OA
1. Joint pain – worse with use or activity
2. Transient post-resting joint stiffness
3. Loss of movement or pain on movement with restricted range
4. Tenderness – articular and peri-articular
5. Bony and soft tissue swelling
6. Crepitus
Why do some patients with OA experience pain and others don’t?
- Pain may arise from stretching of the capsule and/or “inflammation” in the synovium (MRI studies show that change in synovial thickening correlates with change in pain severity (r = 0.3, P <0.005)
- Pain may arise from the bone – there is a correlation between pain and bone marrow oedema lesions on MRI (longitudinal studies show that when pain gets worse, BMLs get larger)
List 5 Current Drug Therapy in OA.
- Proposed Therapy Pyramid in OA?
- Effect size of OA therapies?
- Advantages & Limitations?
Current Drug Therapy in OA
1. Analgesics
2. NSAIDs – topical and oral (parenteral rarely used in chronic disease)
3. Coxibs
4. IA Glucocorticoids
5. IA Hyaluronan
List 5 Possible future therapies for OA?
Possible future therapies for OA
1. CINODs (cyclo-oxygenase inhibiting nitric oxide donors, e.g. Naproxcinod)
2. Topical NSAIDs with improved drug delivery.
3. IL-1 antagonists (Orthokine, Anakinra, Canakinumab for selected disease)
4. Regenerative strategies - autologous chondrocytes (ACI) & autologous stem cells
5. Improved surgical techniques
List the Radiological features of OA (6) vs. RA (4)?
Diagnosis of OA?
- When to consider additional testing?
Diagnosis of OA
Clinical diagnosis - can be made confidently on clinical grounds alone if the following are present:
- persistent activity related pain in one or several joints
- age ≥45 years
- morning stiffness ≤30 minutes
When to consider additional testing
- younger individuals with joint symptoms/signs of OA
- presence of atypical symptoms and signs
- presence of weight loss or constitutional symptoms
Rheumatoid Arthritis - Epidemiology
- Prevalence?
- Median age at diagnosis?
- Gender?
Rheumatoid Arthritis - Epidemiology
- 1% population
- median age at dx = 50yr
- females x 3
What causes RA?
Describe the pathophysiology?
RA - Cause… (unknown)
Multifactorial
- genes + environment
- associated with HLA-DR4
Immune-mediated attack on joints
- Activated T-cells, macrophages, fibroblasts = Produce inflammatory cytokines…
Inflammation of synovium
- Proliferation, fluid secretion
- Invasion of cartilage and bone, joint destruction
- ?over-simplification
Rheumatoid Arthritis
- Presentation?
- Diagnosis?
- Early recognition?
RA - Presenting complaint
- Joint pains = “Inflammatory”
- Improved with activity & NSAIDs
- Worsened by rest
- Morning stiffness >1hr (fluid resorbed)
- Joint swelling
- Polymyalgic symptoms
- Systemic symptoms = fatigue, vasculitis, fever…
JOINT PAIN – Don’t just use SOCRATES!
Rheumatoid Arthritis
- Describe the joint involvement?
- 2 typical features on clinical examination?
- Which 2 conditions are associated & their treatments?
**RA - Joint involvement **
- Symmetrical
- Polyarticular (May be oligoarticular at onset)
- Small and large joints
- MCPs, wrists, MTPs = RA until proven otherwise
- PIPs NOT DIPs
- Knee, shoulder, hip, ankle (most peripheral joints)
- Cervical spine, TMJ - Will not involve the lower back!
- PMR – up to 30% will have - Tx = steroids (15mg) 12months
- Consider GCA - gold standard diagnosis = temporal artery biopsy (can also ultrasound) - Tx = steroids (50mg)
What is the most common cause of joint pain?
= viral
List the investigations you would order for suspected RA? (8)
- What Abs and what %?
List 7 Extra-articular manifestations of RA?
RA – Extra-articular manifestations
1. Nodules (RF+)
2. Ocular – Sicca (dry mucous membranes/eyes), epi/scleritis
3. Pulmonary - Nodules, serositis, alveolitis, fibrosis
4. Neuropathy - Entrapment, mononeuritis, peripheral neuropathy, cervical myelopathy
5. Vasculitis
6. Splenomegaly + Neutropaenia = Felty’s syndrome (extraordinarily rare)
7. Cardiac - Pericarditis, valvular/ conduction abnormalities
- Pay attention to cardiac risk factors
Outline the treatment for RA? (4)
RA - Treatment
1) Disease-modifying medication
- Methotrexate
- Leflunomide, Hydroxychloroquine, Sulfasalazine
2) Anti-inflammatories
- Prednisolone
- NSAIDs
3) Biological agents
4) Monitoring/ treatment of related conditions = Heart disease, osteoporosis
Main tx for RA: Low-dose Methotrexate
- MOA?
- Dosing?
- What must you also prescribe?
- 6 symptoms of methotrexate toxicity?
Other than methotrexate, list 4 other DMARDs you may use in the management of RA?
- MOA?
- Dosing?
- Toxicity/SEs?
What is Tumour Necrosis Factor (TNF)?
- List 6 anti-TNF bDMARDs?
Tumour Necrosis Factor (TNF)
- Key pro-inflammatory cytokine
- Secreted by macrophages, lymphocytes
- Stimulates cell activation, adhesion molecules, enzyme induction, other pro-inflammatory CKs
- Elevated levels in RA serum, synovium
- TNF transgenic mice - erosive arthritis
Discuss the Biological Agents used in RA
- Side effects?
- Monitoring - which 3 blood tests? Treatment efficacy?
Biological Agents in RA
- Well-tolerated
- Increased infection risk
- TB = Need to screen for TB as will cause dissemination of ghon complex
- Upper respiratory tract, soft tissue infections
- ? Increased malignancy risk Skin cancers
- Similar efficacy across the group
List the non-pharmacological treatments of RA?
RA – Other treatment aspects
- Physiotherapy = Improve strength, function (incl. Hydrotherapy)
- Occupational therapy - Wrist splints, Functional aids
- Support groups
- Surgery - Wrist fusion, MCP prosthetics = Becoming less common
What is Pyrophosphate Arthropathy?
Pyrophosphate Arthropathy
- A chronic arthropathy in which the deposition of calcium pyrophosphate in the articular cartilage is considered pathogenic.
- There may be a family history - up to 30% of cases are now thought to be heritable.
- Like gout it may present in an acute form, usually as a monoarthritis (pseudogout), generally affects large joints and is characterized by an intense synovitis, which may be accompanied by systemic symptoms and signs, such as fever, very rarely it may be migratory.
- CPPD is rarely palpable in the soft tissues , unlike urate in gouty tophi
- An example of pseudogout affecting the shoulder is shown in the next slide.
What is Chondrocalcinosis?
- Who gets it?
- What disease should you suspect?
Chondrocalcinosis
- Calcification in the articular cartilage or meniscal cartilage or fibrocartilage ( e.g. triangular ligament in the carpus)
- Increases with age and very common in the elderly (affects approx. 30% of persons over 80 yrs).
- Pseudogout or pyrophosphate arthropathy should be suspected if there is chondrocalcinosis in a symptomatic joint.
What is pseudorheumatoid pyrophosphate arthropathy?
One form of PPA is referred to as pseudorheumatoid pyrophosphate arthropathy
- Multiple affected joints
- Often symmetrical joint involvement
- Due to the pattern of joint involvement and the symmetry, it can be difficult to distinguish from RA
- The presence of chondrocalcinosis in X-rays and CPPD crystals in joint tissue or aspirates is discriminatory.
- An example is shown in the next slide.
Describe the athroscopic appearance & morphology of CPPD deposits?
What is the Treatment of Pyrophosphate Arthropathy and Pseudogout?
Arthroscopic appearance of CPPD deposits
- In some cases, CPPD can be seen in the articular cartilage.
- It can be difficult to distinguish from Urate deposits.
- Sometimes CPPD and Urate co-exist.
- Biopsies of joint tissue should be placed in absolute alcohol (which preserves the crystalline material), NOT formalin.
Morphology of CPPD
- CPPD crystals are rhomboidal and are positively birefringent under polarized light.
- Urate crystals in contrast are needle shaped and negatively birefringent under polarized light
Gout
- Epidemiology?
- Presentation of attacks?
- Pyramid of severity/symptoms?
Gout
- Still the commonest inflammatory disease of the joints in men.
- Affects 1.4% of the adult population in urban Australia and 4% of Aboriginal Australians.
- Acute attacks may be infrequent in the “prodromal phase” of chronic and destructive gout.
- 90% of attacks of gout are monoarticular and the MTP1 joint is most commonly affected.
- Distal joints (e.g. IPs in fingers, IT and MTP joints in the feet) are much more often affected than proximal.
- Prevalence in USA has doubled in the past 20 years – dietary factors may be highly important, especially in men (increased fructose intake).
List the Risk Factors for Gout
- 4 Natural?
- 4 Iatrogenic?
Risk Factors for Gout
Natural
1. Renal disease
2. Alcohol
3. Dietary fructose intake
4. High cell turnover e.g. leukaemia, lymphoma, psoriasis
Iatrogenic
1. Chemotherapy
2. Diuretics
3. Low dose aspirin
4. Other drugs e.g. cyclosporin
Laboratory Findings in Gout?
Laboratory Findings
- Identification of urate (sodium monourate or SMU) crystals either in an inflamed or uninflamed joint is diagnostic.
- Serum urate can be misleading as it may fall during an acute attack and is not always elevated in between attacks.
- An elevated serum urate does not confirm gout and a normal or low serum urate does not exclude it.
Use of Imaging studies to diagnose gout
- Plain xrays?
- US?
- MRI?
- Dual energy CT?
Use of Imaging studies to diagnose gout
- Plain X-rays – have the capacity to identify gouty erosions
- US - has the capacity to identify gouty erosions in multiple joints without use of ionising radiation
- MRI – high sensitivity for gouty erosions and tophaceous deposits, also very useful for assessing the extent of gouty synovitis
- Dual energy CT – capable of detecting urate deposits in joints and soft tissues, high sensitivity and specificty, exposure to moderate ionising radiation, may be pos. when aspirate reveals no crystals. Could be a game changer! A new imaging modality which has a high sensitivity for urate deposition (deposits shown in green). CPPD crystal deposits cannot be imaged with this methodology.
Treatment of Gout
- Acute attack? What should you check for?
- Long-term management?
- 4 New therapies?
Treatment of Gout
- For the acute attack, moderate to high dose short acting NSAIDs are best (eg Indocid 50 mg qid) together with immobilisation of the affected part)
- Following the acute attack consider whether there are reversible factors eg excess alcohol, diuretics, inappropriate diet.
- Check for renal disease
List 5 Spondyloarthropathies.
- 6 Characteristic features?
Spondyloarthropathies
1. Ankylosing spondylitis
2. Psoriatic arthritis
3. Reactive arthritis
4. Enteropathic arthritis
5. Undifferentiated spondyloarthritis
Characteristic features
1. Enthesitis
2. Inflammatory back pain
3. Asymmetrical peripheral oligoarthritis
4. Dactylitis
5. Extra skeletal features
6. Association with HLA-B27
What is Enthesis?
- Which joints are most affected?
What is Dactylitis?
Enthesis
- Site of attachment of ligament/ tendon into bone
- Inflammation (enthesitis) = primary site of pathology in SpA
- Affects the vertebrae, sacroiliac jts, peripheral joints
- Leads to underlying bony reaction
- Also manifest by Achilles tendonitis, plantar fasciitis
Describe the typical features of Inflammatory Back Pain/Ank spond back pain? (9)
Inflammatory Back Pain
1. Morning stiffness >30 min
2. Improvement with exercise, Not with rest
3. Insidious onset
4. Onset <40yo
5. Persistence >3mon
6. Improvement with NSAIDs
7. Alternating buttock pain
8. Awakening in the second half of the night - Due to back/ buttock pain (Family history of SpA)
- Describe the peripheral arthritis in Ankylosing spondylitis?
- What are the 3 extra-skeletal features of Ank-spond?
Peripheral Arthritis
- Asymmetrical
- Oligoarthritis < 4 joints
- Lower limb - Knees, hips, ankles
Ankylosing Spondylitis = The “prototype” SpA
- Epidemiology: prevalence? gender? which HLA association? onset?
- 4 features?
- Clinical findings?
- Imaging? (3)
Ankylosing Spondylitis
Epidemiology
- Prevalence ~ 1%
- M:F 2.5:1
- 90% HLA-B27+
- Onset <45yo
Features
1. Inflammatory back pain
2. Alternating buttock pain
3. Enthesitis, Oligoarthritis, Iritis/Colitis/Rash
4. (Cardiac disease, lung fibrosis)
Clinical Findings: Limitation of spinal mobility
- Modified Schober’s test, Occiput-to-wall, lumbar side flexion, chest expansion
Imaging
- Radiographic sacroiliitis - May lag 5-10 yrs after symptom onset
- Spinal syndesmophytes
- MRI - Enthesitis, bone marrow oedema, erosions, sclerosis
Ankylosing Spondylitis = The “prototype” SpA
- Evolution?
- Management?
Management
- Exercise & NSAIDs - For all! = May be enough
- DMARDs if peripheral arthritis = Methotrexate, sulfasalazine
- TNF inhibitors: Adalimumab, Etanercept, & Infliximab
Psoriatic Arthritis
- How many people with psoriasis will get psoriatic arthritis?
- Joint patterns?
Psoriatic Arthritis
- Up to 30% of patients with psoriasis
Various joint patterns
- Asymmetrical LL oligoarthritis
- Symmetrical polyarthritis
- Spondylarthritis
- 50% HLA-B27+
- DIP arthritis
- Arthritis mutilans
List the clinical features/clue that might suggest psoriatic arthritis?
Management of Psoriatic arthritis?
Clues
- Psoriasis! - Check extensor surfaces, scalp (postauricular), natal cleft, umbilicus
- Family history
- Nail changes - Pitting, ridging, onycholysis, hyperkeratosis
- Dactylitis
- X-ray changes = “Chunky” syndesmophytes & Osteolysis, new bone formation
Reactive Arthritis
- Overview: How does it present in developed countries vs. returned travellers? Which pathologies?
- Pattern?
- 5 Other features?
- Management?
Overview
- Sterile peripheral arthritis
- Within 1/12 of primary infection elsewhere
- Developed countries - Urogenital infection = Chlamydia trachomatis
- Returned travellers - Gastrointestinal infection = Salmonella, Shigella, Yersinia, Campylobacter
Pattern = Usually an asymmetrical LL oligoarthritis - Often florid
Other features
1. Urethritis / diarrhoea
2. Ocular inflammation
3. Enthesitis
4. Dactylitis
5. Mucocutaneous lesions
Enteropathic Arthritis
- Overview: What % of Crohn’s patients? Pattern?
- Which HLA association?
- 3 Other features?
- Management?
Mechanical Back Pain
- Who gets it?
- Clinical presentation?
- 6 Red flags?
- Management? (6)
Mechanical Back Pain
- Older age group
- Gradual onset
- Intermittent exacerbations
- Worse in pm
- Worse with activity
- Can be stiff in am, 5-10 mins
Back Pain - Red Flags
1. Sudden onset
2. Nocturnal pain - Wakes from sleep
3. Weight loss
4. Fevers, sweats
5. Neurological symptoms - Lower limb, sphincters
6. PHx of Cancer - X-ray, bone scan, other Ix (mammogram)
List 5 Connective Tissue Diseases.
Connective Tissue Diseases
1. Systemic Lupus Erythematosus (SLE) - Anti-phospholipid syndrome
2. Scleroderma
3. Sjogren’s Syndrome
4. Inflammatory myopathies
5. Other - Mixed CTD, Vasculitis, Sarcoidosis
Systemic Lupus Erythematous (SLE)
- Epidemiology: Incidence? Prevalence? Gender?
- Risk factors? (4)
SLE – Risk Factors
1. Genetics - Twin studies
o 25-50% concordance for monozygotic twins
o 2-5 % for dizygotic twins
2. Susceptibility alleles - HLA-DR2, DR3
o RR 2-5x
3. Inherited complement deficiencies - C4a deficiency & C1q deficiency
4. Environment
- Hormonal factors No convincing increased risk with OCP
- Smoking
- Infections - eg. EBV
- Stress
List the Organ-specific vs. Systemic autoimmune diseases?
Organ-specific autoimmune disease
1. Thyroid - Hashimoto’s, primary myxedema, thyrotoxicosis
2. Stomach - pernicious anaemia
3. Adrenal - Addison’s disease
4. Pancreas - insulin dependent DM
Systemic autoimmune diseases - SLE
1. CNS Disease
2. Rash
3. Pleuritis
4. Pericarditis
5. Glomerulonephritis
6. Raynaud’s phenomenon
7. Arthritis